Who is sponsoring NCT06025292?

NCT06025292 is sponsored by University of Arkansas.

What drugs are being tested in NCT06025292?

Interventions in NCT06025292: Lean Pork vs Plant-Based Protein.

What condition does NCT06025292 study?

NCT06025292 studies Hyperglycaemia (Non Diabetic), Prediabetes.

Is NCT06025292 still recruiting?

NCT06025292 is currently recruiting now. Last updated 18 July 2025.

Last reviewed 2025-07-18 · How we verify

NCT06025292: PORK

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Lean Pork Loin Intake on Protein Homeostasis and Glucose Regulation in Prediabetic Adults

Recruiting now NA Last updated 18 July 2025

What this trial tests

NA trial testing Lean Pork vs Plant-Based Protein in Hyperglycaemia (Non Diabetic) in 20 participants. Currently enrolling.

Timeline

11 September 2024

Primary endpoint
31 May 2026

30 November 2026

Quick facts

Lead sponsor	University of Arkansas
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	11 September 2024
Primary completion	31 May 2026
Estimated completion	30 November 2026
Sites	1 location across United States

Drugs / interventions tested

Lean Pork vs Plant-Based Protein

Conditions studied

Hyperglycaemia (Non Diabetic) — all drugs for Hyperglycaemia (Non Diabetic) →
Prediabetes — all drugs for Prediabetes →

Sponsor

University of Arkansas

Who can join

Adults 40 to 65, any sex, with Hyperglycaemia (Non Diabetic) or Prediabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We will be directly comparing a high-quality protein diet composed primarily of lean pork loin (PORK) to a lower-quality plant-based protein diet (PLANT) in individuals with prediabetes on muscle and whole-body protein turnover and glucose regulation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hyperglycaemia (Non Diabetic)

Currently open trials in the same condition.

NCT07248761 — Early Hydrocortisone Versus Regular Treatment in Shock in Extremely Preterm Neonates - an Open Randomized Controlled Tri · Phase 4 · active not recruiting

Other University of Arkansas trials

Trials by the same sponsor.

NCT07029776 — MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma · Phase 2 · not yet recruiting
NCT07341399 — Essential Amino Acid Supplementation in Adult Spinal Deformity Patients · NA · not yet recruiting
NCT07071766 — Improving Outcomes for Early Postpartum Mothers in Outpatient MOUD Treatment · NA · recruiting
NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
NCT06604065 — Essential Amino Acids and Parkinsons Disease · Phase 1 · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06025292 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Arkansas
Last refreshed: 18 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06025292.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing